KOREA WHO
-
-
-
CEO of FutureChem
Chi Dae-yoon
Radiopharmaceutical Expert Targets Global Market With Prostate Cancer Pipeline
-
Last Updated on Dec 23, 2025
-
CEO of FutureChem
Life Summary
Ji Dae-yoon (Chi Dae-yoon) is the CEO of FutureChem.
He is focusing on developing diagnostic and therapeutic radiopharmaceuticals with the goal of realizing theranostics. He is also accelerating efforts to expand into the global market.
He was born on August 13, 1955, in Busan.
He graduated from the Department of Chemistry at Sogang University, earned a master’s degree in organic chemistry from KAIST (Korea Advanced Institute of Science and Technology), and received a Ph.D. in organic chemistry from the University of Illinois Urbana-Champaign in the United States.
He completed postdoctoral research at the University of California, Berkeley, and worked as a researcher in the Catalytic Chemistry Laboratory at KAIST and as a senior researcher at the Applied Science Research Division.
He later joined the Department of Chemistry at Inha University as a professor and founded FutureChem in 1999. He then moved to his alma mater, Sogang University, where he served as a professor in the Department of Chemistry.
He is an owner-manager with an academic background.
He is widely regarded as having a high level of expertise in the field of radiopharmaceuticals.
He places strong emphasis on technology.
He served as chairman of the Society of Radiopharmaceutical Sciences (SRS) and was selected as a permanent fellow of the Society of Radiopharmaceutical Sciences in 2021.
#JiDaeYoon #ChiDaeYoon #FutureChem #radiopharmaceuticals #theranostics #nuclearmedicine #biography #KoreanCEO #drugdevelopment #globalmarket
He is focusing on developing diagnostic and therapeutic radiopharmaceuticals with the goal of realizing theranostics. He is also accelerating efforts to expand into the global market.
He was born on August 13, 1955, in Busan.
He graduated from the Department of Chemistry at Sogang University, earned a master’s degree in organic chemistry from KAIST (Korea Advanced Institute of Science and Technology), and received a Ph.D. in organic chemistry from the University of Illinois Urbana-Champaign in the United States.
He completed postdoctoral research at the University of California, Berkeley, and worked as a researcher in the Catalytic Chemistry Laboratory at KAIST and as a senior researcher at the Applied Science Research Division.
He later joined the Department of Chemistry at Inha University as a professor and founded FutureChem in 1999. He then moved to his alma mater, Sogang University, where he served as a professor in the Department of Chemistry.
He is an owner-manager with an academic background.
He is widely regarded as having a high level of expertise in the field of radiopharmaceuticals.
He places strong emphasis on technology.
He served as chairman of the Society of Radiopharmaceutical Sciences (SRS) and was selected as a permanent fellow of the Society of Radiopharmaceutical Sciences in 2021.
#JiDaeYoon #ChiDaeYoon #FutureChem #radiopharmaceuticals #theranostics #nuclearmedicine #biography #KoreanCEO #drugdevelopment #globalmarket